accountPfizer Inc.’s long dependence on the cholesterol pill Lipitor to produce almost one-fifth of the company’s revenue begins eroding today when the drug’s patent protection ends in the U.S.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer Needs to Rebuild After Lipitor
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account